Iovance Biotherapeutics IOVA
NASDAQ IOVA
$14.44 +3.45 (+31.35%)
As of: Sep 29, 2026 · 3:59 PM EDT

Iovance Biotherapeutics (IOVA) Share-based Compensation (IS) (2024 - 2026)

Updated

Iovance Biotherapeutics (IOVA) recorded Share-based Compensation (IS) of $200,000 in Q2 2026, down 33.3% from $300,000 a year earlier and down 33.3% from the prior quarter.

Analysis

Iovance Biotherapeutics (IOVA) Share-based Compensation (IS) (2024 - 2026) Analysis & Trends

On a TTM basis, Iovance Biotherapeutics' Share-based Compensation (IS) came in at $1.1 million as of Jun 30, 2026.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Iovance Biotherapeutics 4.98 Bn 3.77 Bn 55.72 Mn 200,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 200,000.00
Mar 31, 2026 300,000.00
Sep 30, 2025 300,000.00
Jun 30, 2025 300,000.00
Mar 31, 2025 400,000.00
Sep 30, 2024 400,000.00
API Access

Iovance Biotherapeutics Share-based Compensation (IS) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=IOVA&period=max&api_key=YOUR_API_KEY